首页 › 基金 › Shah Wealth Advisors, LLC › CRSP

Shah Wealth Advisors, LLC 对 CRSP 的持仓历史

CRISPR THERAPEUTICS AG NAMEN AKT · 医疗保健

Shah Wealth Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 CRSP(CRISPR THERAPEUTICS AG NAMEN AKT)111,328 股,市值约 US$6.2M,约占其申报组合的 1.22%,在其申报持仓中市值排名第 21 位。 Shah Wealth Advisors, LLC 最近 2 个申报季度中有 2 个季度披露了 CRSP 持仓,最早可追溯至 Q2 2026。

最新持仓 (Q3 2026)111.33K 股
申报持仓市值$6.16M
组合权重1.22%
首次申报Q2 2026
最近变动增持
更新于2026-11-07

最后更新: 2026-11-07 · 来源: SEC EDGAR Form 13F-HR

Shah Wealth Advisors, LLC 对 CRSP 的持仓演变

Shah Wealth Advisors, LLC 于 Q2 2026 首次披露 CRSP 持仓:69,060 股(约 US$3.8M)。 该持仓在 Q3 2026 达到峰值 111,328 股,市值约 US$6.2M。 在 2 次申报中,Shah Wealth Advisors, LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 111,328 股、市值约 US$6.2M,环比增持 42,268 股。。 持仓曾出现大幅变动:Q3 2026 增持约 61% (随后一个季度股价下跌 9%)。

逐季持仓明细

季度股数金额变化
Q2 2026 69.06K $3.77M 新进
Q3 2026 111.33K $6.16M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CRSP 与 13F 数据

CRSP(CRISPR THERAPEUTICS AG NAMEN AKT)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 CRSP,申报仓位最大的包括:方舟投资 (US$516.0M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$144.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CRSP 的基金

查看 CRSP 的全部基金持有人 →

常见问题

How long has Shah Wealth Advisors, LLC held CRSP?

Shah Wealth Advisors, LLC has disclosed CRSP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Shah Wealth Advisors, LLC's current position in CRSP?

As of Q3 2026, Shah Wealth Advisors, LLC holds 111.33K shares of CRSP (CRISPR THERAPEUTICS AG NAMEN AKT), valued at $6.16M, representing 1.22% of its reported portfolio and ranking #21.

Has Shah Wealth Advisors, LLC been buying or selling CRSP?

In the latest 13F filing (Q3 2026), Shah Wealth Advisors, LLC increased its position in CRSP. The position peaked in Q3 2026 at 111.33K shares.

Which other funds hold CRSP?

Other major institutional holders of CRSP include 方舟投资, Orbis Allan Gray Ltd, GSK plc, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.